Genomes.io aim to build the largest user-owned genomic data bank and secure the future of personalised medicine. Once the store of data grows, they expect significant demand from research and pharma companies, as Genomes can provide better DNA acquisition, more cohesive insights and take full responsibility for its data security, unlike competitors. This will allow them to scale up and build strategic partnerships within the medical world. Secure, protected genome sequencing currently backed by Consensys and AMD. National government interest. Genomes sequence the entire genome to give customers a full in-depth understanding of their biology, whereas competitors sequence just 0.02%. EIS